Because of these functions, the overexpression of EGFR confers great advantages on tumoral cells in epithelial cancers, such as in 15–30% of breast cancers, 60% of lung cancers, and 80% of colorectal cancers [33]. The gene discussed is EGFR; the disease is colorectal cancer.